Mark Kurth

Dr. Mark Kurth


Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2005 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
CYChoong Leol Yoo
Choong Leol Yoo
JFJames C. Fettinger
James C. Fettinger
MKMark Kurth
Mark Kurth

29 June 2012 in Organic Letters
Verified
Journal Article
Closed access
KGKathryn G. Guggenheim
Kathryn G. Guggenheim
HTHannah Toru
Hannah Toru
MKMark Kurth
Mark Kurth

20 August 2013 in Organic Letters
Verified
Journal Article
Closed access
HNHuy H. Nguyen
Huy H. Nguyen
TPTeresa A. Palazzo
Teresa A. Palazzo
MKMark Kurth
Mark Kurth

26 December 2012 in Organic Letters
Verified
Journal Article
Closed access
HNHuy H. Nguyen
Huy H. Nguyen
MKMark Kurth
Mark Kurth

26 November 2012 in Hepatology
Verified
Journal Article
Open access
PDF file
RCRichy C.Y. Chen
Richy C.Y. Chen
PNPhornnop Naiyanetr
Phornnop Naiyanetr
SSShang-An Shu
Shang-An Shu
JWJinjun Wang
Jinjun Wang
GYGuo-Xiang Yang
Guo-Xiang Yang
PLPatrick S.C. Leung
Patrick S.C. Leung
Antimitochondrial antibodies (AMAs) directed against the lipoyl domain of the E2 subunit of pyruvate dehydrogenase (PDC-E2) are detected in 95% of patients with primary biliary cirrhosis (PBC) and are present before the onset of clinical disease. The recent demonstration that AMAs recognize xenobiotic modified PDC-E2 with higher titers than native PDC-E2 raises the possibility that the earliest events involved in loss of tolerance are related to xenobiotic modification. We hypothesized that reactivity to such xenobiotics would be predominantly immunoglobulin M (IgM) and using sera from a large cohort of PBC patients and controls (n = 516), we examined in detail sera reactivity against either 6,8-bis(acetylthio) octanoic acid (SAc)-conjugated bovine serum albumin (BSA), recombinant PDC-E2 (rPDC-E2) or BSA alone. Further, we also defined the relative specificity to the SAc moiety using inhibition enzyme-linked immunosorbent assay (ELISA); SAc conjugate and rPDC-E2-specific affinity-purified antibodies were also examined for antigen specificity, isotype, and crossreactivity. Reactivity to SAc conjugates is predominantly IgM; such reactivity reflects a footprint of previous xenobiotic exposure. Indeed, this observation is supported by both direct binding, crossreactivity, and inhibition studies. In both early and late-stage PBC, the predominant Ig isotype to SAc is IgM, with titers higher with advanced stage disease. We also note that there was a higher level of IgM reactivity to SAc than to rPDC-E2 in early-stage versus late-stage PBC. Interestingly, this finding is particularly significant in light of the structural similarity between SAc and the reduced form of lipoic acid, a step which is similar to the normal physiological oxidation of lipoic acid. Conclusion: Specific modifications of the disulfide bond within the lipoic-acid-conjugated PDC-E2 moiety, i.e., by an electrophilic agent renders PDC-E2 immunogenic in a genetically susceptible host.

24 September 2012 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
JKJohn M. Knapp
John M. Knapp
JZJie S. Zhu
Jie S. Zhu
DTDean Tantillo
Dean Tantillo
MKMark Kurth
Mark Kurth